Raymond James & Associates Purchases New Position in LHC Group, Inc. (LHCG)

Raymond James & Associates purchased a new position in shares of LHC Group, Inc. (NASDAQ:LHCG) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 2,835 shares of the health services provider’s stock, valued at approximately $243,000.

Several other hedge funds also recently modified their holdings of the company. Cubist Systematic Strategies LLC increased its stake in shares of LHC Group by 36.9% during the 1st quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after purchasing an additional 711 shares during the last quarter. Meadow Creek Investment Management LLC increased its stake in shares of LHC Group by 29.2% during the 2nd quarter. Meadow Creek Investment Management LLC now owns 3,220 shares of the health services provider’s stock worth $276,000 after purchasing an additional 728 shares during the last quarter. Xact Kapitalforvaltning AB increased its stake in shares of LHC Group by 19.7% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 4,865 shares of the health services provider’s stock worth $416,000 after purchasing an additional 800 shares during the last quarter. Glen Harbor Capital Management LLC increased its stake in shares of LHC Group by 29.2% during the 2nd quarter. Glen Harbor Capital Management LLC now owns 3,910 shares of the health services provider’s stock worth $335,000 after purchasing an additional 884 shares during the last quarter. Finally, Crossmark Global Holdings Inc. increased its stake in shares of LHC Group by 28.2% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 6,506 shares of the health services provider’s stock worth $557,000 after purchasing an additional 1,433 shares during the last quarter. Institutional investors own 86.24% of the company’s stock.

LHC Group stock opened at $91.95 on Friday. LHC Group, Inc. has a 1-year low of $58.65 and a 1-year high of $103.79. The company has a market capitalization of $2.80 billion, a P/E ratio of 38.00, a price-to-earnings-growth ratio of 1.40 and a beta of 0.52. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.18.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.95. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The business had revenue of $507.00 million during the quarter, compared to analyst estimates of $515.03 million. During the same period in the previous year, the business earned $0.64 EPS. LHC Group’s revenue was up 88.0% compared to the same quarter last year. Sell-side analysts forecast that LHC Group, Inc. will post 3.52 EPS for the current year.

In related news, COO Donald Dwayne Stelly sold 2,756 shares of LHC Group stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $99.32, for a total value of $273,725.92. Following the completion of the transaction, the chief operating officer now directly owns 104,512 shares in the company, valued at approximately $10,380,131.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jeff Reibel sold 1,921 shares of LHC Group stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $94.12, for a total transaction of $180,804.52. Following the completion of the transaction, the senior vice president now owns 8,125 shares of the company’s stock, valued at $764,725. The disclosure for this sale can be found here. 6.80% of the stock is currently owned by insiders.

Several equities research analysts have recently issued reports on the stock. William Blair restated a “buy” rating on shares of LHC Group in a research note on Thursday. Craig Hallum lowered shares of LHC Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $99.00 to $92.00 in a research note on Friday, October 26th. BidaskClub upgraded shares of LHC Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 28th. Bank of America set a $119.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research note on Tuesday, September 18th. Finally, SunTrust Banks raised their price target on shares of LHC Group to $115.00 and gave the stock a “buy” rating in a research note on Thursday, September 13th. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $103.00.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

See Also: What does cost of debt say about a company’s financial health?

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply